0001209191-21-018358.txt : 20210305 0001209191-21-018358.hdr.sgml : 20210305 20210305183319 ACCESSION NUMBER: 0001209191-21-018358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210303 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BLANK BURKHARD CENTRAL INDEX KEY: 0001073409 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31938 FILM NUMBER: 21720037 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 BUSINESS PHONE: 914-347-4300 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-03 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001073409 BLANK BURKHARD 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 0 1 0 0 CMO and Head of R&D Common Stock 2021-03-03 4 A 0 11125 0.00 A 18527 D Award of restricted stock units, each representing a contingent right to one share of common stock which, subject to continued service, vests in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date. Holdings were adjusted to reflect the issuer's 1-for-6 reverse stock split effected on December 31, 2020. /s/ Burkhard Blank 2021-03-05